Dr. Jeremy P. Feldman, MD

Dr. Feldman practices at Summit Health in Bend, Oregon.

Dr. Feldman's NPI, 1689681025, was assigned on August 1, 2006. Dr. Feldman graduated from UC San Diego School of Medicine in 1998. Dr. Feldman's Oregon license number on file is MD207608.

Dr. Feldman's primary practice is Summit Health, at 1501 Ne Medical Center Dr, Bend, OR 97701. The practice phone is (541) 382-2811.

Dr. Feldman's primary practice is Summit Health in Bend, Oregon. Dr. Feldman is also affiliated with St. Charles Bend. The medical group on file is Summit Health. Dmand AI also links Dr. Feldman to 3 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Feldman is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Feldman's licenses on file in 4 states: Oregon, Arizona, California and Massachusetts.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, chronic sinusitis, lung resection, pleural effusion and pneumonia among the conditions Dr. Feldman treats.

CMS data shows 4,191 Medicare services from Dr. Feldman across 34 procedure codes in 2024, for 734 Medicare patients. Medicare paid $243,289 for them.

CMS counts 734 Medicare patients who saw Dr. Feldman in 2024. The largest group is 75 to 84, with 334 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 71, with 60% women.

In 2024, Dr. Feldman wrote 3,247 Medicare Part D claims for 494 patients. 60% of them were for generic drugs. CMS names the drug for 2,951 of them, across 54 drugs with 11 or more claims each, at $4,349,689 in total drug cost. In 2023, CMS named 2,893 claims across 50 drugs.

Dr. Feldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feldman as offering telehealth.

Dmand AI links 53 papers to Dr. Feldman, published from 2010 to 2024. 2020 was the busiest year, with 6. The most frequent topics are Hypertension, Pulmonary, Antihypertensive Agents and Epoprostenol. Dr. Feldman has published most often in Pulm Circ. Dr. Feldman's most frequent co-authors are Murali M. Chakinala, MD, Stephen Carl Mathai, MD, MHS and David B. Badesch, MD.

Dmand AI links Dr. Feldman to 16 clinical trials, 7 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Pulmonary Arterial Hypertension, Hypertension, Pulmonary and Pulmonary Fibrosis. United Therapeutics sponsors the most, 4.

CMS Open Payments shows 671 general payments to Dr. Feldman from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $200,377. It also lists 1 research payment totaling $99 in 2020.

Dmand AI lists 1 award for Dr. Feldman, most recently CMS Stage 1 2012 in 2011.

Dr. Feldman graduated from UC San Diego School of Medicine in 1998.

Dr. Feldman is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.